IDEAYA reports preliminary Q2 cash of $952.7M; sells 922k shares via ATM at ~$40.40

IDEAYA Biosciences, Inc.

Preliminary cash, cash equivalents & marketable securities of ~$952.7M as of June 30, 2024 (unaudited).
Sold 922,000 shares via ATM at weighted avg price of ~$40.40/share between Apr 1 and Jul 5, 2024.
Remaining ATM capacity of ~$182.1M of common stock available for sale as of July 5, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.